Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PloS one. 2010;5(5):e10855.
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer prevention research (Philadelphia, Pa.). 2010;3(5):597-603.
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas. The Journal of pathology. 2010;221(1):57-67.
Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer causes & control : CCC. 2010;21(5):737-43.
TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell cycle (Georgetown, Tex.). 2010;9(6):1143-55.
Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19(3):838-43.
Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clinical colorectal cancer. 2010;9(3):168-76.
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British journal of cancer. 2010;102(2):447-54.
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment. Breast cancer research and treatment. 2010;119(1):33-8.
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. British journal of cancer. 2010;103(12):1875-84.